Advertisement
Advertisement
Trending on Urology Times
1
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
2
Vanquish Water Vapor System used in first commercial prostate ablation
3
Phase 1/2 trial launches of molecular glue degrader for ccRCC
4
Interpreting PSMA PET Imaging in Prostate Cancer
5